Qianjiang Yongan Pharmaceutical Co., Ltd. (SHE:002365)
China
· Delayed Price · Currency is CNY 14.58
+0.29 (2.03%)
Mar 11, 2026, 9:25 AM CST
SHE:002365 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 10, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 4,216 | 2,327 | 2,882 | 3,094 | 3,122 | 2,689 | Upgrade
|
| Market Cap Growth | 70.50% | -19.26% | -6.86% | -0.90% | 16.11% | -7.45% | Upgrade
|
| Enterprise Value | 3,361 | 1,513 | 2,049 | 2,440 | 2,756 | 2,238 | Upgrade
|
| Last Close Price | 14.58 | 7.96 | 9.61 | 10.21 | 10.32 | 9.02 | Upgrade
|
| PE Ratio | 167.20 | 37.67 | - | 22.08 | 28.97 | 25.48 | Upgrade
|
| Forward PE | - | 6.36 | 6.36 | 6.36 | 6.36 | 6.36 | Upgrade
|
| PS Ratio | 5.29 | 2.77 | 2.96 | 2.12 | 2.00 | 2.29 | Upgrade
|
| PB Ratio | 2.09 | 1.14 | 1.41 | 1.47 | 1.60 | 1.48 | Upgrade
|
| P/TBV Ratio | 2.22 | 1.22 | 1.52 | 1.61 | 1.77 | 1.62 | Upgrade
|
| P/FCF Ratio | 108.79 | - | 28.69 | 12.99 | 80.55 | 26.30 | Upgrade
|
| P/OCF Ratio | 37.95 | 22.01 | 13.03 | 7.99 | 30.67 | 13.01 | Upgrade
|
| EV/Sales Ratio | 4.22 | 1.80 | 2.11 | 1.67 | 1.76 | 1.91 | Upgrade
|
| EV/EBITDA Ratio | 36.78 | 9.91 | 12.86 | 8.31 | 11.45 | 9.30 | Upgrade
|
| EV/EBIT Ratio | - | 37.86 | 84.93 | 14.36 | 22.08 | 17.53 | Upgrade
|
| EV/FCF Ratio | 86.72 | - | 20.39 | 10.25 | 71.09 | 21.88 | Upgrade
|
| Debt / Equity Ratio | 0.01 | 0.02 | 0.01 | 0.02 | 0.01 | 0.07 | Upgrade
|
| Debt / EBITDA Ratio | 0.31 | 0.26 | 0.06 | 0.14 | 0.08 | 0.51 | Upgrade
|
| Debt / FCF Ratio | 0.73 | - | 0.10 | 0.17 | 0.53 | 1.20 | Upgrade
|
| Net Debt / Equity Ratio | -0.44 | -0.43 | -0.46 | -0.38 | -0.27 | -0.34 | Upgrade
|
| Net Debt / EBITDA Ratio | -9.78 | -5.77 | -5.94 | -2.70 | -2.19 | -2.60 | Upgrade
|
| Net Debt / FCF Ratio | -23.06 | 71.45 | -9.42 | -3.33 | -13.60 | -6.12 | Upgrade
|
| Asset Turnover | 0.35 | 0.36 | 0.41 | 0.62 | 0.70 | 0.58 | Upgrade
|
| Inventory Turnover | 7.97 | 8.24 | 6.58 | 6.71 | 10.66 | 8.83 | Upgrade
|
| Quick Ratio | 4.59 | 4.38 | 4.41 | 3.60 | 3.04 | 2.97 | Upgrade
|
| Current Ratio | 5.02 | 4.83 | 4.72 | 4.19 | 3.63 | 3.31 | Upgrade
|
| Return on Equity (ROE) | 0.85% | 2.92% | -1.37% | 6.54% | 6.31% | 6.84% | Upgrade
|
| Return on Assets (ROA) | -0.12% | 1.07% | 0.63% | 4.51% | 3.51% | 3.92% | Upgrade
|
| Return on Invested Capital (ROIC) | -0.34% | 2.98% | -9.39% | 10.75% | 8.74% | 9.89% | Upgrade
|
| Return on Capital Employed (ROCE) | -0.20% | 1.90% | 1.20% | 7.90% | 6.30% | 6.90% | Upgrade
|
| Earnings Yield | 0.60% | 2.65% | -0.43% | 4.54% | 3.57% | 3.92% | Upgrade
|
| FCF Yield | 0.92% | -0.53% | 3.49% | 7.70% | 1.24% | 3.80% | Upgrade
|
| Dividend Yield | 0.70% | 1.26% | 1.04% | 0.98% | - | 1.11% | Upgrade
|
| Payout Ratio | 72.17% | 48.27% | - | 1.11% | 27.59% | 43.08% | Upgrade
|
| Buyback Yield / Dilution | 0.95% | 0.52% | -0.13% | -2.66% | 0.63% | -0.06% | Upgrade
|
| Total Shareholder Return | 1.64% | 1.77% | 0.92% | -1.68% | 0.63% | 1.05% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.